The effect of aflatoxin B_1 and HBV X gene on expression profiles of drug-meta bolizing enzymes genes in transgenic mice with HBVx gene by cDNA microarray
Hao Zhang
Abstract
Hao Zhang
Abstract
Objective To investigate difference of gene expression profiles for drug-metabolizing enzymes by AFB 1 treatment and HBV X gene expression inducing hepatocarcinogenesis in transgenic mice with HBVx gen e and to explore the molecular mechanism of the synergetic hepatocarcinogenesis effect of both HBV and AFB 1 in the development of HCC.Methods Using BiostarM-40s cDNA microarray to analyze the diff erent expression of liver tissues between the blank group and the experimental g roups including HBVx group, AFB 1 group and the combine group of HBVx and AFB 1.Results Evident difference was observed in experimental groups when compared with the blank group. The number of aberrant expressions including up-regulated and down-regulated genes in HBVx group, AFB 1 group and the com bine group were 35,101 and 69,respectively. We also found 18 aberrant expression which involved in metabolizing enzymes, among 18 genes, 4 out of 18 (22%) in HB Vx group, 8 out of 18 (44%) in AFB 1 group and 13 out of 18 (72%) in the combin e group.Conclusion The gene expression levels of those genes encoding d rug-metabolizing enzymes including GST,EPHX and UDPGT are significantly lower in mice, which suffered from dual attack of HBV X gene plus AFB 1 than in those which suffered from single attack of HBV X gene or AFB 1.The mechanisms of HBV and AFB 1-induce synergetic hepatocarcinogenesis may be correlation with the expression levels down-regulated of drug-metabolizing enzymes genes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate difference of gene expression profiles for drug-metabolizing enzymes by AFB 1 treatment and HBV X gene expression inducing hepatocarcinogenesis in transgenic mice with HBVx gen e and to explore the molecular mechanism of the synergetic hepatocarcinogenesis effect of both HBV and AFB 1 in the development of HCC.Methods Using BiostarM-40s cDNA microarray to analyze the diff erent expression of liver tissues between the blank group and the experimental g roups including HBVx group, AFB 1 group and the combine group of HBVx and AFB 1.Results Evident difference was observed in experimental groups when compared with the blank group. The number of aberrant expressions including up-regulated and down-regulated genes in HBVx group, AFB 1 group and the com bine group were 35,101 and 69,respectively. We also found 18 aberrant expression which involved in metabolizing enzymes, among 18 genes, 4 out of 18 (22%) in HB Vx group, 8 out of 18 (44%) in AFB 1 group and 13 out of 18 (72%) in the combin e group.Conclusion The gene expression levels of those genes encoding d rug-metabolizing enzymes including GST,EPHX and UDPGT are significantly lower in mice, which suffered from dual attack of HBV X gene plus AFB 1 than in those which suffered from single attack of HBV X gene or AFB 1.The mechanisms of HBV and AFB 1-induce synergetic hepatocarcinogenesis may be correlation with the expression levels down-regulated of drug-metabolizing enzymes genes.
Key concepts: Gene, Complementary DNA, Gene expression, Molecular biology, Biology, Microarray, Aflatoxin, Enzyme